ribose

Ribose is a pentose sugar existing in both open-chain and cyclic (furanose) forms, with D-ribose being the biologically relevant enantiomer. Its 2'-hydroxyl group distinguishes RNA from DNA (which contains deoxyribose, lacking this OH group), making RNA more chemically reactive and susceptible to hydrolysis.

Ribose is generated primarily through the pentose phosphate pathway (PPP), a metabolic pathway occurring in the cytoplasm that branches from glycolysis. The PPP has two phases: the oxidative phase (irreversible, generates NADPH and ribulose-5-phosphate from glucose-6-phosphate via glucose-6-phosphate dehydrogenase, the rate-limiting enzyme) and the non-oxidative phase (reversible, interconverts various sugar phosphates including ribose-5-phosphate). Ribose-5-phosphate is a key precursor for de novo purine and pyrimidine nucleotide synthesis, combining with ATP via PRPP synthetase to form phosphoribosyl pyrophosphate (PRPP), which is essential for nucleotide biosynthesis.

Clinical significance includes: - G6PD deficiency: X-linked disorder impairing NADPH production, leading to hemolytic anemia under oxidative stress (e.g., fava beans, sulfa drugs, infections) due to insufficient glutathione regeneration. - PRPP synthetase overactivity: Can cause gout and hyperuricemia due to excessive purine synthesis. - Ribose is also a component of coenzymes like NAD+, NADP+, FAD, and CoA, linking it to broader metabolic processes including cellular respiration and redox reactions. - Ribose sugars are structurally implicated in antiviral drug design, as many nucleoside analogs (e.g., acyclovir, AZT) modify the ribose moiety to inhibit viral replication.

Understanding ribose's role bridges biochemistry, genetics, and pharmacology, making it a recurring theme in USMLE Step 1 questions regarding metabolism, enzyme deficiencies, and nucleotide synthesis pathways.